Results 1 to 10 of about 42,495 (262)

Placental Expression of proBNP/NT-proBNP and Plasma Levels of NT-proBNP in Early- and Late-Onset Preeclampsia [PDF]

American Journal of Hypertension, 2014
Levels of plasma N-terminal pro B-type natriuretic peptide (NT-proBNP) are elevated in preeclampsia. In this study, the possibility that the placenta produces and releases proBNP/NT-proBNP was explored. Plasma levels of NT-proBNP in early- and late-onset preeclampsia were also measured.Placental proBNP mRNA in early-onset preeclampsia (n = 7), late ...
Anna-Karin Wikstrom, , JUNUS Katja
exaly   +3 more sources

NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients [PDF]

BMC Geriatrics
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is useful to predict adverse outcomes. Change in NT-proBNP level may provide additional actionable risk assessment information. This study aimed to determine the association of change in NT-
Jinling Ma, Ang Li, Suyan Bian
doaj   +2 more sources

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD

Indian Pacing and Electrophysiology Journal
Aims: Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study was to compare urinary NT-proBNP to plasma NT-proBNP in a
Benedikt Seither, Alexander Schober, Raphael Allgaier, Christine Meindl, Michael Paulus, Ute Hubauer, Andreas Schober, Ekrem Ücer, Sabine Fredersdorf, Petra Lehn, Andreas Keyser, Andreas Luchner, Lars Maier, Stefan Wallner, Carsten Jungbauer   +14 more
doaj   +3 more sources

Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair

ESC Heart Failure, 2021
Aims This multicentre study investigated the association of periprocedural changes in the levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) with clinical outcomes after transcatheter edge‐to‐edge mitral valve repair (TMVR).
Tetsu Tanaka, Refik Kavsur, Maximilian Spieker, Christos Iliadis, Clemens Metze, Patrick Horn, Atsushi Sugiura, Malte Kelm, Stephan Baldus, Georg Nickenig, Ralf Westenfeld, Roman Pfister, Marc Ulrich Becher   +12 more
doaj   +1 more source

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure

The Egyptian Heart Journal, 2023
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body mass index (BMI). The study aimed to explore the impact of BMI on NT-proBNP
Tuan Ha Manh, Duong Do Anh, Tung Le Viet
doaj   +1 more source

The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease

Frontiers in Cardiovascular Medicine, 2021
Background: The N-terminal pro B type natriuretic peptide (NT-proBNP) is important for prognosis of heart failure in patients with chronic kidney disease (CKD).
Sheng Wang, Ming Li, Xiangyu Wang, Jing Luo, Yulin Zou, Yang Hu, Xingtai Liu, Hua Ao, Xueer Yao, Chufeng Li, Tingting Yang   +10 more
doaj   +1 more source

Impact of socioeconomic and cardiovascular risk factors on the effect of genetic variants associated with NT-proBNP

Scientific Reports, 2022
N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is an established biomarker for diagnosis of heart failure. The study aims to explore whether known cardiovascular risk factors, including education and income as indicators of socioeconomic ...
Emanuel Matusch, Mirjam Frank, Kaffer Kara, Amir A. Mahabadi, Nico Dragano, Raimund Erbel, Karl-Heinz Jöckel, Börge Schmidt   +7 more
doaj   +1 more source

NT-proBNP

Journal of the American College of Cardiology, 2016
BACKGROUND: Pulmonary hypertension (PH) is a serious complication to interstitial lung disease (ILD) and has a poor prognosis. PH is often diagnosed by screening with echocardiography followed by right heart catheterisation. A previous study has shown that a value of NT-pro-brain natriuretic peptide (NT-proBNP) <95 ng/l could be used to rule out PH ...
Andersen, Charlotte, Mellemkjær, Søren, Hilberg, Ole, Bendstrup, Elisabeth; id_orcid 0000-0002-4238-6963   +3 more
openaire   +3 more sources

Levels of NT‑proBNP in patients with cancer

Oncology Letters, 2023
At present, it is well known that natriuretic peptides may be produced by cancer cells. Stimulation of N-terminal pro B-type natriuretic peptide (NT-proBNP) synthesis may be a reaction to activity of several proinflammatory cytokines. NT-proBNP is also a marker of myocardial damage during cardiotoxic chemotherapy by anthracyclines.
Jozef, Chovanec, Jozef, Chovanec, Michal, Chovanec, Michal, Mego   +3 more
openaire   +2 more sources

Characterization of NT-proBNP in Human Urine [PDF]

Clinical Chemistry, 2009
Abstract Background: Urine amino-terminal probrain natriuretic peptide (NT-proBNP) concentrations may exclude the presence of heart failure and provide insight into renal clearance mechanisms for human NT-proBNP. We characterized the molecular forms of urine NT-proBNP detected by immunoassay.
Suetonia C, Palmer, Zoltan H, Endre, A Mark, Richards, Timothy G, Yandle   +3 more
openaire   +2 more sources